New Cosponsor — Feb 1, 2012
New Cosponsor: Sen. Jeff Bingaman [D-NM, 1983-2012]
The bill now has 9 cosponsors (6 Democrats, 2 Republicans, 1 Independent).
Kickstarter calls GovTrack Insider a “Project We Love”
We’re trying to hire a full-time researcher, but we need your help.
Jan 25, 2011
112th Congress, 2011–2013
This bill was introduced on July 21, 2011, in a previous session of Congress, but was not enacted.
Senator from Wisconsin
Read Text »
Last Updated: Jul 22, 2011
Length: 18 pages
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Reported by Committee
Last Action: Oct 15, 2009
The “S.” in “S. 27” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 27 — 112th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/112/s27
“S. 27 — 112th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2011. August 28, 2015 <https://www.govtrack.us/congress/bills/112/s27>
|title=S. 27 (112th)
|accessdate=August 28, 2015
|author=112th Congress (2011)
|date=January 25, 2011
|quote=Preserve Access to Affordable Generics Act